Company profile
Baiyining company profile
Baiyining engaged in the precise tumor immunotherapy market and related scientific research. They provides a variety of tumor immune cell therapy technologies, including autologous tumor antigens, DCs, TILs, cytokines, and other comprehensive immune status assessment technologies in parallel, and develop on this basis the identification and screening of specific tumor neoantigen technology.
Business identity
- Website
- https://www.byn.org/
- Operating status
- Active
- Company type
- For Profit
- Revenue range
- $1K+
Headquarters
- Headquarters
- Genhe, Inner Mongolia, China
- Country code
- CN
- Continent
- Asia